Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Testosterone tablet: Phase III

In a U.S. Phase III trial in 98 patients, COL-1621 treatment resulted in mean testosterone blood levels of 5.3 ng/mL,

Read the full 209 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE